First Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, 510080, China
NCT Number: NCT02999451
POEM is a new intervention for the treatment of achalasia and has been reported to relieve the dysphagia symptom effectively. Although the cost of POEM method is less than the method of Laparoscopic Heller Myotomy and Fundoplication, it is still of an economic burden for the patients with achalasia. In this trial, investigators plan to use snare to assist POEM procedure, to observe the safety, efficacy and cost-effectiveness of this method, compared with other knifes-assisted procedure.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Guangzhou, Guangdong, 510080, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
POEM is performed by using a snare which is retracted into the sheath to expose the tip, leaving a 1-2mm length for operation.
POEM is performed by using a conventional endoscopic knife.
Time frame: 12 months after treatment
Clinical success is defined as a post-POEM Eckardt score ≤3 without additional treatment (Eckardt AJ et al, Nat Rev Gastroenterol Hepatol 2011).
Time frame: baseline to 12 months after treatment
Adverse events are defined and graded according to the American Society for Gastrointestinal Endoscopy lexicon (Cotton PB et al, Gastrointest Endosc 2010). Incidental findings of pneumoperitoneum, pneumothorax, pneumomediastinum, pleural effusion on postoperative imaging, and subcutaneous emphysema were documented while not considered as adverse events.
Time frame: POEM procedure
Procedure time is measured from the start of submucosal injection until mucosal entry closure.
Time frame: POEM procedure
Time frame: POEM procedure
Time frame: Through hospital stay after procedure, an average of 2-7 days
Pain related to POEM procedure requiring the use of tramadol pain medication.
Time frame: Through hospital stay after procedure, an average of 2-7 daysc
Time frame: Through hospital stay after procedure, an average of 2-7 days
Time frame: baseline, 3 months and 12 months after treatment
The Eckardt score assesses the severity of achalasia symptoms by combining the sum of symptom frequency scores for dysphagia, regurgitation, and chest pain and a weight loss score. Each component can be graded from 0 to 3 points. The total range is 0 to 12, with higher scores indicating more severe symptoms (Eckardt AJ et al, Nat Rev Gastroenterol Hepatol 2011).
Time frame: baseline and 3 months after treatment
Manometry parameters include lower esophageal sphincter (LES) pressure and integrated relaxation pressure (IRP) on high resolution manometry.
Time frame: baseline and 3 months after treatment
Time frame: baseline, 3 months and 12 months after treatment
The GerdQ has been developed as a tool to facilitate the symptom-based diagnosis of GERD. Scores ranging from 0 to 3 were applied for the four positive predictors (heartburn, regurgitation, sleep disturbance due to reflux symptoms and use of over-the-counter medications for reflux symptoms) and from 3 to 0 for two negative predictors (epigastric pain and nausea). The GerdQ score was calculated as the sum of these scores, giving a total score ranging from 0 to 18. A total GerdQ score >7 is considered indicative of significant GERD symptoms (Jones R et al, Aliment Pharmacol Ther 2009).
Time frame: 3 months after treatment
The severity of reflux esophagitis is graded according to the Los Angeles classification (Armstrong D et al, Gastroenterology 1996).
First Affiliated Hospital, Sun Yat-Sen University
Other
Safety, Efficacy and Cost-effectiveness of Snare-assisted POEM for Treatment of Esophageal Achalasia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04112693
Deglutition Disorders, Digestive System Diseases
Nantes, France
View Trial DetailsNCT03702647
Achalasia, Deglutition Disorders
Kingston, Ontario, Canada
View Trial DetailsNCT03944863
Deglutition Disorders, Digestive System Diseases
View Trial DetailsNCT00490750
Deglutition Disorders, Digestive System Diseases
St Louis, Missouri, United States
View Trial Details